This inventor holds 2 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1976-1978.
Company Filing History:
Years Active: 1976-1978
Title: The Innovative Contributions of Seth S. Mizuba
Introduction
Seth S. Mizuba is a notable inventor based in Morton Grove, IL (US). He has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 2 patents, Mizuba's work focuses on the transformation of specific chemical compounds by various microorganisms.
Latest Patents
Mizuba's latest patents include the development of 2-(2-Amino-4-chlorophenoxy)benzyl alcohol and a diacetate derivative of 8-Chloro-10,11-dihydrodibenz[b,f][1,4]oxazepine. These compounds are transformed by various microorganisms into substances that possess useful pharmacological properties or serve as intermediates in the synthesis of various pharmaceutical compounds. The microorganisms utilized for this transformation include Trichoderma lignorum NRRL 8138, Hormodendrum sp. NRRL 8133, Cladosporium lignicolum NRRL 8131, Hormodendrum cladosporioides NRRL 8132, Pullularia pullulans NRRL 8137, Penicillium sp. NRRL 8136, Mucor sp. NRRL 8135, Chaetomium sp. NRRL 8130, and Hormodendrum sp. NRRL 8134.
Career Highlights
Mizuba is currently associated with G.D. Searle & Company, where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the understanding of microbial transformations in drug development.
Collaborations
Mizuba collaborates with James Jiu, enhancing the research and development efforts within their organization.
Conclusion
Seth S. Mizuba's innovative work in the field of pharmaceuticals showcases his dedication to advancing medical science through his inventions. His contributions are significant in the ongoing development of useful pharmacological compounds.